CL2003001192A1 - Composicion inmunogenica meningococica multivalente, de vesiculas de membrana externa, que comprende una vesicula con actividad homologa de un subserotipo prevalente en un pais y otra vesicula con actividad heterologa, que tiene disminuida una protei - Google Patents

Composicion inmunogenica meningococica multivalente, de vesiculas de membrana externa, que comprende una vesicula con actividad homologa de un subserotipo prevalente en un pais y otra vesicula con actividad heterologa, que tiene disminuida una protei

Info

Publication number
CL2003001192A1
CL2003001192A1 CL200301192A CL2003001192A CL2003001192A1 CL 2003001192 A1 CL2003001192 A1 CL 2003001192A1 CL 200301192 A CL200301192 A CL 200301192A CL 2003001192 A CL2003001192 A CL 2003001192A CL 2003001192 A1 CL2003001192 A1 CL 2003001192A1
Authority
CL
Chile
Prior art keywords
activity
subsertipe
multivally
meningococim
vesicula
Prior art date
Application number
CL200301192A
Other languages
English (en)
Spanish (es)
Inventor
Morales Dominguez Alva Barbera
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of CL2003001192A1 publication Critical patent/CL2003001192A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CL200301192A 2002-06-13 2003-06-10 Composicion inmunogenica meningococica multivalente, de vesiculas de membrana externa, que comprende una vesicula con actividad homologa de un subserotipo prevalente en un pais y otra vesicula con actividad heterologa, que tiene disminuida una protei CL2003001192A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0213622.4A GB0213622D0 (en) 2002-06-13 2002-06-13 Vaccine Corporation

Publications (1)

Publication Number Publication Date
CL2003001192A1 true CL2003001192A1 (es) 2005-01-07

Family

ID=9938532

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200301192A CL2003001192A1 (es) 2002-06-13 2003-06-10 Composicion inmunogenica meningococica multivalente, de vesiculas de membrana externa, que comprende una vesicula con actividad homologa de un subserotipo prevalente en un pais y otra vesicula con actividad heterologa, que tiene disminuida una protei

Country Status (20)

Country Link
US (1) US20060110412A1 (enExample)
EP (1) EP1565211A2 (enExample)
JP (1) JP2005531614A (enExample)
KR (1) KR20050049431A (enExample)
CN (1) CN100387298C (enExample)
AR (1) AR040204A1 (enExample)
AU (1) AU2003236734A1 (enExample)
BR (1) BR0311777A (enExample)
CA (1) CA2488782A1 (enExample)
CL (1) CL2003001192A1 (enExample)
CU (1) CU23552A1 (enExample)
GB (1) GB0213622D0 (enExample)
MX (1) MXPA04012568A (enExample)
NO (1) NO20050132L (enExample)
NZ (1) NZ560766A (enExample)
PE (1) PE20040562A1 (enExample)
RU (1) RU2005100509A (enExample)
UY (1) UY27843A1 (enExample)
WO (1) WO2003105890A2 (enExample)
ZA (1) ZA200409547B (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030024811A (ko) 2000-07-27 2003-03-26 칠드런즈 하스피틀 앤드 리써치 센터 앳 오클랜드 나이세리아 메닌지티디스에 의하여 유발되는 질병에 대한광범위하게 유효한 보호를 위한 백신
GB2414667A (en) * 2004-06-03 2005-12-07 Isis Innovation Vaccine compositions of N. meningitidis PorA and FetA antigens
GB0419627D0 (en) * 2004-09-03 2004-10-06 Chiron Srl Immunogenic bacterial vesicles with outer membrane proteins
BRPI0607374B8 (pt) 2005-01-27 2021-05-25 Childrens Hospital & Res Center At Oakland vacinas de vesículas baseadas em gna1870 para proteção de amplo espectro contra doenças causadas por neisseria meningitidis
CA2808919C (en) * 2005-12-22 2016-04-19 Glaxosmithkline Biologicals S.A. Streptococcus pneumoniae capsular saccharide vaccine
SI2097102T1 (sl) 2006-09-07 2012-09-28 Glaxosmithkline Biolog Sa Kombinirano cepivo, ki ima zmanjšane količine antigena za poliovirus
CA2702871A1 (en) 2007-10-19 2009-04-23 Novartis Ag Meningococcal vaccine formulations
JP2011503104A (ja) 2007-11-09 2011-01-27 カリフォルニア インスティテュート オブ テクノロジー 免疫調節化合物ならびに関連組成物および方法
CN105044337A (zh) * 2008-02-01 2015-11-11 圣诺菲·帕斯图尔有限公司 用于诊断肺炎链球菌的试验
DK2268618T3 (en) 2008-03-03 2015-08-17 Novartis Ag Compounds and compositions as TLR aktivitetsmodulatorer
NZ593674A (en) 2008-12-17 2013-03-28 Novartis Ag Meningococcal vaccines including hemoglobin receptor
EP2440245B1 (en) 2009-06-10 2017-12-06 GlaxoSmithKline Biologicals SA Benzonaphthyridine-containing vaccines
AU2010288239B2 (en) 2009-08-27 2014-01-16 Novartis Ag Adjuvant comprising aluminium, oligonucleotide and polycation
SG178954A1 (en) 2009-09-02 2012-04-27 Novartis Ag Immunogenic compositions including tlr activity modulators
TWI445708B (zh) 2009-09-02 2014-07-21 Irm Llc 作為ｔｌｒ活性調節劑之化合物及組合物
EP2486940B1 (en) * 2009-10-08 2017-10-04 Aeon Medix Inc. Composition comprising extracellular membrane vesicles derived from indoor air, and use thereof
WO2011057148A1 (en) 2009-11-05 2011-05-12 Irm Llc Compounds and compositions as tlr-7 activity modulators
MX339146B (es) 2009-12-15 2016-05-13 Novartis Ag Suspension homogenea de compuestos inmunopotenciadores y usos de los mismos.
JP5894083B2 (ja) * 2009-12-22 2016-03-23 サノフィ パストゥール リミテッドＳａｎｏｆｉ Ｐａｓｔｅｕｒ Ｌｉｍｉｔｅｄ 免疫原性組成物
EP2547357A1 (en) 2010-03-18 2013-01-23 Novartis AG Adjuvanted vaccines for serogroup b meningococcus
EP2549990A1 (en) 2010-03-23 2013-01-30 Irm Llc Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc.
WO2011127302A2 (en) * 2010-04-07 2011-10-13 Yue Shen Vehicle for delivering a compound to a mucous membrane and related compositions, methods and systems
US9259462B2 (en) * 2010-09-10 2016-02-16 Glaxosmithkline Biologicals Sa Developments in meningococcal outer membrane vesicles
EP2707009A1 (en) 2011-05-12 2014-03-19 Novartis AG Antipyretics to enhance tolerability of vesicle-based vaccines
EP2731617A4 (en) 2011-07-12 2015-07-01 Brigham & Womens Hospital LIPID-BASED PSA COMPOSITIONS, METHOD FOR THEIR INSULATION AND USE METHOD THEREFOR
ES2654613T3 (es) 2012-02-02 2018-02-14 Glaxosmithkline Biologicals Sa Promotores para una expresión aumentada de proteínas en meningococos
JP2015517089A (ja) 2012-03-08 2015-06-18 ノバルティス アーゲー タンパク質ベースの髄膜炎菌ワクチンのためのインビトロ有効性アッセイ
US10376573B2 (en) 2012-06-14 2019-08-13 Glaxosmithkline Biologicals Sa Vaccines for serogroup X meningococcus
AU2013311702A1 (en) 2012-09-06 2015-02-19 Novartis Ag Combination vaccines with serogroup B meningococcus and D/T/P
US11331335B2 (en) 2015-06-10 2022-05-17 California Institute Of Technology Sepsis treatment and related compositions methods and systems
EP3337321A4 (en) 2015-08-19 2019-07-17 President and Fellows of Harvard College LIPIDED PSA COMPOSITIONS AND METHOD
EP3484441A4 (en) 2016-07-15 2020-03-18 President and Fellows of Harvard College GLYCOLIPID COMPOSITIONS AND METHOD FOR USE
CA3035320A1 (en) 2016-09-02 2018-03-08 Glaxosmithkline Biologicals Sa Vaccines for neisseria gonorrhoeae
CA3166272A1 (en) * 2020-10-23 2022-04-28 Omvax, Inc. Compositions and methods for vaccination against neisseria gonorrhoeae
GB202115077D0 (en) 2021-10-21 2021-12-08 Glaxosmithkline Biologicals Sa Assay

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL338146A1 (en) * 1997-07-17 2000-09-25 North American Vaccine Immunogenic complex combinations consisting of meningococcal porine of b group and h. influenzae polysaccharide
GB9918319D0 (en) * 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
KR20030024811A (ko) * 2000-07-27 2003-03-26 칠드런즈 하스피틀 앤드 리써치 센터 앳 오클랜드 나이세리아 메닌지티디스에 의하여 유발되는 질병에 대한광범위하게 유효한 보호를 위한 백신

Also Published As

Publication number Publication date
KR20050049431A (ko) 2005-05-25
MXPA04012568A (es) 2005-09-21
US20060110412A1 (en) 2006-05-25
WO2003105890A3 (en) 2004-03-25
CN1668329A (zh) 2005-09-14
NO20050132D0 (no) 2005-01-11
CN100387298C (zh) 2008-05-14
CU23552A1 (es) 2010-07-20
AU2003236734A1 (en) 2003-12-31
NZ560766A (en) 2009-09-25
GB0213622D0 (en) 2002-07-24
ZA200409547B (en) 2006-07-26
CA2488782A1 (en) 2003-12-24
BR0311777A (pt) 2005-03-29
PE20040562A1 (es) 2004-10-19
RU2005100509A (ru) 2006-06-10
AR040204A1 (es) 2005-03-16
UY27843A1 (es) 2003-12-31
NO20050132L (no) 2005-02-11
WO2003105890A2 (en) 2003-12-24
JP2005531614A (ja) 2005-10-20
EP1565211A2 (en) 2005-08-24

Similar Documents

Publication Publication Date Title
CL2003001192A1 (es) Composicion inmunogenica meningococica multivalente, de vesiculas de membrana externa, que comprende una vesicula con actividad homologa de un subserotipo prevalente en un pais y otra vesicula con actividad heterologa, que tiene disminuida una protei
BR9813692B1 (pt) processo para produzir uma vacina da proteìna e2 de pestivìrus recombinante em cultura de células de inseto, e, vacina da subunidade e2.
ITMI20042128A1 (it) Componente micromeccanico con una membrana e procedimento per la fabbricazione di un tale componente
WO2003091401A3 (en) Multi plasmid system for the production of influenza virus
ITTO20050168A1 (it) Cassa autoportante in legno adatta al sostegno e all'isolamento termico di una membrana di cisterna a tenuta stagna.
GB0419627D0 (en) Immunogenic bacterial vesicles with outer membrane proteins
ATE312624T1 (de) Impfstoff gegen hpv
AU2002329724A1 (en) High strength asymmetric cellulosic membrane
AR029759A1 (es) Variante de glucoamilasa original, una construccion de adn, un vector de expresion recombinante, una celula, un proceso para convertir almidon, uso de una variante de glucoamilasa para un proceso de fermentacion y metodo para mejorar la estabilidad termica.
AU2001238501A1 (en) Selective destruction of cells infected with human immunodeficiency virus
BR0210803B1 (pt) ionÈmero, método de preparação e membrana eletrolìtica polimérica compreendendo o mesmo, conjunto de eletrodo de membrana e célula combustìvel compreendendo tal conjunto.
IT1317753B1 (it) Cella di elettrolisi con elettrodo a diffusione di gas.
AU2001294752A1 (en) Integral membrane support and frame structure
BR0115775B1 (pt) embalagem que compreende um recipiente e uma membrana.
AU2001269640A1 (en) Vaccine against the influenza virus and method for producing said virus vaccine
NO20005055D0 (no) Gass-separerende membranstruktur av honeycomb type
IT1301717B1 (it) Procedimento di fabbricazione di una membrana scambiatrice di ioni,impiegabile come separatore in una pila a combustibile.
ATE254912T1 (de) Sonnenschutzmittel zur oralen aufnahme
DE60231821D1 (de) Rekombinante tollwut-vakzine und verfahren zu ihrer herstellung und verwendung
AU2001258097A1 (en) Turbomachine with rotor-shroud seal structure
ITMI20032531A1 (it) Cella a combustione a membrana alimentata in
DE60129187D1 (de) Kompositelektrolyt mit Schutzmembran, Herstellungsverfahren dafür und Brennstoffzelle mit einem solchen Elektrolyt
DE60125927D1 (de) Impfstoffe gegen hiv
ITMI20020869A0 (it) Generatore elettrochimico e membrana a ingombro ridotto
DE122011100041I1 (de) In vitro-rekonstitution von segmentierten, negativstrang-rna-viren.